NYSE:BME - Blackrock Health Sciences Trust Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$38.83 -0.42 (-1.07 %)
(As of 01/21/2019 06:53 AM ET)
Previous Close$39.25
Today's Range$38.83 - $39.55
52-Week Range$32.00 - $44.00
Volume32,446 shs
Average Volume37,700 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.06%
BetaN/A
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Receive BME News and Ratings via Email

Sign-up to receive the latest news and ratings for BME and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Closed-End Fund - Equity
Sub-IndustryN/A
SectorFinance
CUSIPN/A
Phone+1-800-8820052

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions

What is Blackrock Health Sciences Trust's stock symbol?

Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust?

Blackrock Health Sciences Trust declared a monthly dividend on Thursday, January 3rd. Shareholders of record on Tuesday, January 15th will be paid a dividend of $0.20 per share on Thursday, January 31st. This represents a $2.40 dividend on an annualized basis and a yield of 6.18%. The ex-dividend date is Monday, January 14th. View Blackrock Health Sciences Trust's Dividend History.

Has Blackrock Health Sciences Trust been receiving favorable news coverage?

News stories about BME stock have been trending somewhat negative on Monday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days.

Who are some of Blackrock Health Sciences Trust's key competitors?

Who are Blackrock Health Sciences Trust's key executives?

Blackrock Health Sciences Trust's management team includes the folowing people:
  • Mr. John M. Perlowski, Chief Exec. Officer and Pres (Age 54)
  • Mr. Neal J. Andrews, Chief Financial Officer (Age 52)
  • Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 51)
  • Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.
  • Mr. Jay M. Fife, Treasurer (Age 48)

Who are Blackrock Health Sciences Trust's major shareholders?

Blackrock Health Sciences Trust's stock is owned by a number of of institutional and retail investors. Top institutional investors include Corrado Advisors LLC (0.00%). Company insiders that own Blackrock Health Sciences Trust stock include Alexander Tsakumis and Gary Gordon Cope. View Institutional Ownership Trends for Blackrock Health Sciences Trust.

Which institutional investors are buying Blackrock Health Sciences Trust stock?

BME stock was purchased by a variety of institutional investors in the last quarter, including Corrado Advisors LLC. Company insiders that have bought Blackrock Health Sciences Trust stock in the last two years include Alexander Tsakumis and Gary Gordon Cope. View Insider Buying and Selling for Blackrock Health Sciences Trust.

How do I buy shares of Blackrock Health Sciences Trust?

Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Blackrock Health Sciences Trust's stock price today?

One share of BME stock can currently be purchased for approximately $38.83.

What is Blackrock Health Sciences Trust's official website?

The official website for Blackrock Health Sciences Trust is http://www2.blackrock.com/global/home/index.htm.

How can I contact Blackrock Health Sciences Trust?

Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.


MarketBeat Community Rating for Blackrock Health Sciences Trust (NYSE BME)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  77 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote "Outperform" if you believe BME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel